Skip to main content

The role of aspirin in cardiovascular diseases--forgotten benefits?

Publication ,  Journal Article
Williams, A; Hennekens, CH
Published in: Expert Opin Pharmacother
January 2004

The increasing burden of cardiovascular diseases in developed, as well as developing countries, underscores the need for the more widespread and appropriate use of aspirin in secondary prevention of occlusive vascular events during acute evolving myocardial infarction (MI) and in primary prevention. Aspirin should be far more widely used in a wide range of patients who have suffered a prior occlusive vascular event and in all patients suffering acute MI or occlusive stroke. Finally, in primary prevention, aspirin should be considered for individuals whose 10-year risks of a coronary event are > or = 10%, as an adjunct not alternative to the management of other risk factors. The more widespread and appropriate use of aspirin will avoid many premature deaths in secondary prevention and MIs in primary prevention.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Expert Opin Pharmacother

DOI

ISSN

1465-6566

Publication Date

January 2004

Volume

5

Issue

1

Start / End Page

109 / 115

Location

England

Related Subject Headings

  • Stroke
  • Randomized Controlled Trials as Topic
  • Pharmacology & Pharmacy
  • Myocardial Infarction
  • Humans
  • Fibrinolytic Agents
  • Dose-Response Relationship, Drug
  • Cardiovascular Diseases
  • Aspirin
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Williams, A., & Hennekens, C. H. (2004). The role of aspirin in cardiovascular diseases--forgotten benefits? Expert Opin Pharmacother, 5(1), 109–115. https://doi.org/10.1517/14656566.5.1.109
Williams, Adam, and Charles H. Hennekens. “The role of aspirin in cardiovascular diseases--forgotten benefits?Expert Opin Pharmacother 5, no. 1 (January 2004): 109–15. https://doi.org/10.1517/14656566.5.1.109.
Williams A, Hennekens CH. The role of aspirin in cardiovascular diseases--forgotten benefits? Expert Opin Pharmacother. 2004 Jan;5(1):109–15.
Williams, Adam, and Charles H. Hennekens. “The role of aspirin in cardiovascular diseases--forgotten benefits?Expert Opin Pharmacother, vol. 5, no. 1, Jan. 2004, pp. 109–15. Pubmed, doi:10.1517/14656566.5.1.109.
Williams A, Hennekens CH. The role of aspirin in cardiovascular diseases--forgotten benefits? Expert Opin Pharmacother. 2004 Jan;5(1):109–115.

Published In

Expert Opin Pharmacother

DOI

ISSN

1465-6566

Publication Date

January 2004

Volume

5

Issue

1

Start / End Page

109 / 115

Location

England

Related Subject Headings

  • Stroke
  • Randomized Controlled Trials as Topic
  • Pharmacology & Pharmacy
  • Myocardial Infarction
  • Humans
  • Fibrinolytic Agents
  • Dose-Response Relationship, Drug
  • Cardiovascular Diseases
  • Aspirin
  • 3214 Pharmacology and pharmaceutical sciences